跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free - TGA Drug Approval Details
Approvals
/
TGA
/
CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free
Approved
STANDARD
CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
fb36c57a00ee87b6
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
fb36c57a00ee87b6
Product Name
CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free
Artg Id
446874
Artg Name
CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2024-04-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
fb36c57a00ee87b6
Type
Standard
Back to TGA Approvals